File Download
  Patent History
  • Application
    PC T/CN2011000322 2011-02-28
  • Publication
    WO 2011103774 2011-09-01

published patent: PHARMACEUTICAL COMPOSITION AND USE THEREOF IN MANUFACTURING MEDICAMENTS FOR TREATING RESPIRATORY DISEASES

TitlePHARMACEUTICAL COMPOSITION AND USE THEREOF IN MANUFACTURING MEDICAMENTS FOR TREATING RESPIRATORY DISEASES
Priority Date2010-02-26 US 12/308597P
Inventors
Issue Date2011
Citation
WO Published patent application WO 2011103774. World Intellectual Property Organization (WIPO), PatentScope, 2011 How to Cite?
AbstractComposition including a neutrophil elastase (NE)-targeting agent that counters the pathologic elements of respiratory inflammation is provided. NE-targeting agents primarily disrupt the association between NE and shed ectodomains of Syn-1, resulting in inhibition of the NE by protease inhibitors or anti-elastases. Non-anticoagulant heparin derivatives or fragments are exemplary NE-targeting agents. The composition preferably includes a carrier, such as chitosan or lactose in dry powder formulations, to facilitate delivery of the active agent. Use of the composition in manufacturing medicaments for treating respiratory diseases is also disclosed.
Persistent Identifierhttp://hdl.handle.net/10722/177157
References

 

DC FieldValueLanguage
dc.date.accessioned2012-11-30T08:39:14Z-
dc.date.available2012-11-30T08:39:14Z-
dc.date.issued2011-
dc.identifier.citationWO Published patent application WO 2011103774. World Intellectual Property Organization (WIPO), PatentScope, 2011en_HK
dc.identifier.urihttp://hdl.handle.net/10722/177157-
dc.description.abstractComposition including a neutrophil elastase (NE)-targeting agent that counters the pathologic elements of respiratory inflammation is provided. NE-targeting agents primarily disrupt the association between NE and shed ectodomains of Syn-1, resulting in inhibition of the NE by protease inhibitors or anti-elastases. Non-anticoagulant heparin derivatives or fragments are exemplary NE-targeting agents. The composition preferably includes a carrier, such as chitosan or lactose in dry powder formulations, to facilitate delivery of the active agent. Use of the composition in manufacturing medicaments for treating respiratory diseases is also disclosed.en_HK
dc.rightsCreative Commons: Attribution 3.0 Hong Kong License For Public Patent Documentsen_US
dc.titlePHARMACEUTICAL COMPOSITION AND USE THEREOF IN MANUFACTURING MEDICAMENTS FOR TREATING RESPIRATORY DISEASESen_HK
dc.typePatenten_US
dc.description.naturepublished_or_final_versionen_US
dc.contributor.inventorShum, DKYen_HK
dc.contributor.inventorIp, MSMen_HK
dc.contributor.inventorChan, Chi Hangen_HK
dc.contributor.inventorLeung, Valeria On Yueen_HK
patents.identifier.applicationPC T/CN2011000322en_HK
patents.description.assigneeUNIV HONG KONG [CN]; SHUM DAISY KWOK YAN [CN]; IP MARY SAU MAN [CN]; CHAN CHI HANG [CN]; LEUNG VALERIA ON YUE [CN]en_HK
patents.description.countryWorld Intellectual Property Organization (WIPO)en_HK
patents.date.publication2011-09-01en_HK
dc.relation.referencesWO 9906025 (A1) 1999-02-11en_HK
dc.relation.referencesCN 1197587 (C) 2005-04-20en_HK
dc.relation.referencesCN 1327795 (A) 2001-12-26en_HK
dc.relation.referencesCN 1278820 (A) 2001-01-03en_HK
dc.relation.referencesCN 1287852 (C) 2006-12-06en_HK
dc.relation.referencesCN 1306435 (A) 2001-08-01en_HK
patents.date.application2011-02-28en_HK
patents.date.priority2010-02-26 US 12/308597Pen_HK
patents.description.ccWOen_HK
patents.identifier.publicationWO 2011103774en_HK
patents.relation.familyUS 2011212181 (A1) 2011-09-01en_HK
patents.relation.familyWO 2011103774 (A1) 2011-09-01en_HK
patents.description.kindA1en_HK
patents.typePatent_publisheden_HK

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats